Zobrazeno 1 - 8
of 8
pro vyhledávání: '"H V Marquart"'
Autor:
S. Modvig, H. O. Madsen, S. M. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen, L. T. N. Osnes, H. Vålerhaugen, M. Hultdin, I. Thörn, R. Matuzeviciene, M. Stoskus, M. Marincevic, L. Fogelstrand, A. Lilleorg, N. Toft, O. G. Jónsson, K. Pruunsild, G. Vaitkeviciene, K. Vettenranta, B. Lund, J. Abrahamsson, K. Schmiegelow, H. V. Marquart
Publikováno v:
Leukemia. 34:1719-1720
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21dcded3e3ad5364eb4b706b91cac588
https://doi.org/10.1038/s41375-019-0672-9
https://doi.org/10.1038/s41375-019-0672-9
Autor:
Peter Junker, R. G. Q. Leslie, Anders Jørgen Svendsen, S E Svehag, J M Rasmussen, Claus Henrik Nielsen, H. V. Marquart
Publikováno v:
Marquart, H V, Svendsen, A J, Rasmussen, J M, Nielsen, C H, Junker, P, Svehag, S E & Leslie, R G 1995, ' Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE) ', Clinical and Experimental Immunology, vol. 101, no. 1, pp. 60-65 . https://doi.org/10.1111/j.1365-2249.1995.tb02277.x
It has previously been reported that the expression of the complement receptors, CR1 on erythrocytes and blood leucocytes and CR2 on B cells, is reduced in patients with SLE, and that the reduced expression of CR1 on erythrocytes is related to diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d357f8e8866370f37faba8fe092be163
https://doi.org/10.1111/j.1365-2249.1995.tb02277.x
https://doi.org/10.1111/j.1365-2249.1995.tb02277.x
Publikováno v:
Scandinavian Journal of Immunology. 40:228-236
The binding of opsonized, fluorescein-labelled bovine serum albumin (BSA)/rabbit anti-BSA complexes (IC) to washed human whole blood cells and isolated leucocytes in the presence of autologous serum was investigated by flow cytometry. In the presence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a82b2850e0807e8615e45088b8e20e
https://doi.org/10.1111/j.1365-3083.1994.tb03455.x
https://doi.org/10.1111/j.1365-3083.1994.tb03455.x
Publikováno v:
The Journal of Immunology. 153:307-315
Human cells infected with certain viruses acquire the ability to activate the alternative pathway (AP) of complement. Complement receptor 2 on EBV-infected lymphoblastoid cell lines has been reported to act as the covalent binding site for C3b during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::091c639161673dc7abc1f57977a2ed8c
https://doi.org/10.4049/jimmunol.153.1.307
https://doi.org/10.4049/jimmunol.153.1.307
Publikováno v:
Scandinavian journal of immunology. 46(3)
Contradictory reports regarding the ability of complement receptor type 2 (CR2,CD21) on normal B cells to activate complement (C') via the alternative pathway (AP), prompted us to compare the performance of human peripheral blood B cells and the Epst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42702de9863abeb582f7433ee11cd259
https://pubmed.ncbi.nlm.nih.gov/9315112
https://pubmed.ncbi.nlm.nih.gov/9315112
Previous studies from this laboratory have shown that normal peripheral blood B cells are capable of activating complement via the alternative pathway (AP), that the activation is associated with complement receptor type 2 (CR2) expression, and that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea69a62ca14947da06dbe85f8266dadc
https://europepmc.org/articles/PMC1364021/
https://europepmc.org/articles/PMC1364021/
Publikováno v:
Scopus-Elsevier
SUMMARYIt has previously been reported that the expression of the complement receptors CRI (CD35) and CR2 (CD21) on malignant B cells in CLL is reduced compared with the expression on normal B cells, while deposition of complement C3 fragments, as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62df3c581139b69a993acde7e9295ac7
https://europepmc.org/articles/PMC1553367/
https://europepmc.org/articles/PMC1553367/
Publikováno v:
Complement (Basel, Switzerland). 5(2)
The expression of C3dg/Epstein-Barr virus receptors (CR2) on human peripheral blood and tonsillar B lymphocytes and Raji cells was quantified by measuring binding of unlabeled monoclonal anti-CR2 antibody (OKB7 and HB-5) in an indirect immunoenzymati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3584b568ef3002ed7e3951c68d9e9fce
https://pubmed.ncbi.nlm.nih.gov/2837360
https://pubmed.ncbi.nlm.nih.gov/2837360